Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Loading
Home›
Research›
Investment Firms›
Mayo Clinic Ventures
AddedFeb 13, 2024
UpdatedJun 28, 2026
Mayo Clinic Ventures

Mayo Clinic Ventures

Operating

Mayo Medical Ventures: A US-based venture capital firm investing in healthcare, IT, and medical devices.

Location
Rochester, MN, US
Founded
1986
Firm
Compare
Portfolio
Employees

Investments

The Patient Company
The Patient Company

Total Raised

$6.5M

Rounds

14

Convertible Note$1MJanuary 2022
Jogo Health
Jogo Health

Total Raised

$10.4M

Rounds

3

Seed$4.6MAugust 2021
R-Zero
R-Zero

Total Raised

$170M

Rounds

6

Series B$50MJune 2021
Helix
Helix

Total Raised

$403M

Rounds

5

Series C$50MJune 2021
Anumana
Anumana

Total Raised

$117.7M

Rounds

4

Series B$60MMay 2021
Series A$25.7MApril 2021
TripleBlind
TripleBlind

Total Raised

$32.2M

Rounds

3

Seed$8.2MMarch 2021
nference
nference

Total Raised

$152.7M

Rounds

7

Series C$66MDecember 2020
Series B$69MJanuary 2020
Progentec Diagnostics
Progentec Diagnostics
Public

Total Raised

$6.3M

Rounds

3

Series A$5MJanuary 2020
Series Unknown$1.3MNovember 2017
Novome Biotechnologies
Novome Biotechnologies

Total Raised

$83.1M

Rounds

6

Series A$33MJanuary 2020
Elysium Health
Elysium Health

Total Raised

$71.2M

Rounds

8

Series C$40MDecember 2019
Cadence Neuroscience
Cadence Neuroscience

Total Raised

$41M

Rounds

3

Series A$15MOctober 2019
Qlaris Bio
Qlaris Bio

Total Raised

$25M

Rounds

1

Series A$25MAugust 2019
Marigold Health
Marigold Health

Total Raised

$21.5M

Rounds

12

Pre-SeedJuly 2018
Vineti
Vineti

Total Raised

$115.3M

Rounds

4

Series B$33.5MApril 2018
Series A$13.8MJune 2017
Geneticure
Geneticure

Total Raised

$6M

Rounds

6

Seed$1.4MApril 2018
Unity Biotechnology
Unity Biotechnology
Public

Total Raised

$294.9M

Rounds

9

Series B$35MAugust 2017
Epirium Bio
Epirium Bio

Total Raised

$86.4M

Rounds

3

Series Unknown$192kJanuary 2016
Lifecode
Lifecode
Acquired

Total Raised

$20.5M

Rounds

2

Series A$20.5MFebruary 2015
Kardia Health Systems
Kardia Health Systems
Acquired

Total Raised

$18.9M

Rounds

3

Series Unknown$3.3MAugust 2007
Naviscan
Naviscan

Total Raised

$26.8M

Rounds

6

Series C$15MMay 2007
Series B$6.5MNovember 2005